Citadel Advisors’s ICU Medical ICUI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$43.1M Buy
333,336
+122,437
+58% +$17.6M 0.01% 1509
2025
Q4
$30.1M Buy
+210,899
New +$28.3M ﹤0.01% 1900
2025
Q2
Sell
-148,427
Closed -$20.1M 13666
2025
Q1
$20.6M Sell
148,427
-243,083
-62% -$37.7M ﹤0.01% 2003
2024
Q4
$60.8M Sell
391,510
-261,831
-40% -$44.3M 0.01% 1111
2024
Q3
$119M Buy
653,341
+447,512
+217% +$66.3M 0.02% 600
2024
Q2
$24.4M Buy
205,829
+15,088
+8% +$1.59M ﹤0.01% 1799
2024
Q1
$20.5M Buy
190,741
+82,693
+77% +$8.22M ﹤0.01% 2032
2023
Q4
$10.8M Buy
108,048
+104,345
+2,818% +$10.2M ﹤0.01% 2738
2023
Q3
$441K Buy
3,703
+3,505
+1,770% +$523K ﹤0.01% 8341
2023
Q2
$35.3K Buy
+198
New +$36.3K ﹤0.01% 12187
2022
Q3
Sell
-12,106
Closed -$2.01M 13054
2022
Q2
$1.99M Buy
12,106
+6,173
+104% +$1.19M ﹤0.01% 5557
2022
Q1
$1.32M Sell
5,933
-77,908
-93% -$17.5M ﹤0.01% 7052
2021
Q4
$19.9M Buy
83,841
+13,530
+19% +$3.16M ﹤0.01% 2028
2021
Q3
$16.4M Sell
70,311
-139,178
-66% -$29.2M ﹤0.01% 2288
2021
Q2
$43.1M Buy
209,489
+27,125
+15% +$5.58M 0.01% 1259
2021
Q1
$37.5M Buy
182,364
+89,115
+96% +$18.8M 0.01% 1301
2020
Q4
$20M Buy
93,249
+75,506
+426% +$14.6M 0.01% 1808
2020
Q3
$3.24M Sell
17,743
-8,361
-32% -$1.57M ﹤0.01% 3855
2020
Q2
$4.81M Sell
26,104
-466,204
-95% -$92.6M ﹤0.01% 3142
2020
Q1
$99.3M Buy
492,308
+60,938
+14% +$11.7M 0.04% 338
2019
Q4
$80.7M Buy
431,370
+175,629
+69% +$30.2M 0.04% 507
2019
Q3
$40.8M Buy
255,741
+241,707
+1,722% +$48.1M 0.02% 892
2019
Q2
$3.54M Buy
14,034
+8,955
+176% +$2.08M ﹤0.01% 3605
2019
Q1
$1.22M Sell
5,079
-20,757
-80% -$4.98M ﹤0.01% 5237
2018
Q4
$5.93M Sell
25,836
-34,589
-57% -$8.53M ﹤0.01% 2551
2018
Q3
$17.1M Buy
60,425
+35,308
+141% +$10.3M 0.01% 1541
2018
Q2
$7.38M Buy
25,117
+23,747
+1,733% +$6.49M ﹤0.01% 2271
2018
Q1
$346K Sell
1,370
-48,224
-97% -$11.3M ﹤0.01% 6508
2017
Q4
$10.7M Sell
49,594
-47,985
-49% -$9.71M 0.01% 1669
2017
Q3
$18.1M Buy
+97,579
New +$17M 0.01% 1135
2017
Q2
Sell
-3,533
Closed -$539K 7726
2017
Q1
$539K Sell
3,533
-10,271
-74% -$1.5M ﹤0.01% 4895
2016
Q4
$2.03M Buy
13,804
+26
+0.2% +$3.76K ﹤0.01% 2932
2016
Q3
$1.74M Sell
13,778
-31,222
-69% -$3.77M ﹤0.01% 3130
2016
Q2
$5.07M Buy
45,000
+13,127
+41% +$1.36M 0.01% 1811
2016
Q1
$3.32M Sell
31,873
-14,502
-31% -$1.39M ﹤0.01% 2161
2015
Q4
$5.23M Sell
46,375
-18,492
-29% -$2.04M 0.01% 1777
2015
Q3
$7.1M Buy
+64,867
New +$6.94M 0.01% 1600
2015
Q2
Sell
-38,429
Closed -$3.58M 8872
2015
Q1
$3.58M Buy
38,429
+13,737
+56% +$1.2M ﹤0.01% 2393
2014
Q4
$2.02M Buy
24,692
+3,522
+17% +$270K ﹤0.01% 2896
2014
Q3
$1.36M Sell
21,170
-5,002
-19% -$306K ﹤0.01% 3318
2014
Q2
$1.59M Buy
26,172
+11,410
+77% +$674K ﹤0.01% 2964
2014
Q1
$884K Sell
14,762
-19,442
-57% -$1.2M ﹤0.01% 3583
2013
Q4
$2.18M Buy
34,204
+17,052
+99% +$1.1M ﹤0.01% 2466
2013
Q3
$1.17M Buy
17,152
+12,629
+279% +$902K ﹤0.01% 2936
2013
Q2
$326K Buy
+4,523
New +$299K ﹤0.01% 4221

Other funds holding ICUI

Citadel Advisors's ICUI Position: Q1 2026 in Review

Citadel Advisors increased its ICU Medical (ICUI) stake by 58% in Q1 2026, buying an estimated $17.6M and bringing the position to 333,336 shares worth $43.1M. The position accounts for 0.01% of the portfolio, ranked #1509.

Citadel Advisors first reported a position in ICUI in Q2 2013 and has held it in 45 quarters since. The position peaked at $119M in Q3 2024. 275 funds tracked by Wall St. Rank hold ICUI as of Q1 2026.

  • Citadel Advisors held 333,336 shares of ICU Medical worth $43.1M as of Q1 2026.
  • Citadel Advisors bought 122,437 ICU Medical shares in Q1 2026, an estimated $17.6M.
  • ICU Medical made up 0.01% of Citadel Advisors's portfolio in Q1 2026, its #1509 holding.
  • Citadel Advisors first reported a position in ICU Medical in Q2 2013 and has held it in 45 quarters since.
  • Citadel Advisors's ICU Medical position peaked at $119M in Q3 2024.
  • 275 funds tracked by Wall St. Rank held ICU Medical as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.